SopD2 is a novel type III secreted effector of Salmonella typhimurium that targets late endocytic compartments upon delivery into host cells
about
The small RNA SgrS: roles in metabolism and pathogenesis of enteric bacteriaComparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoidAn extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their disseminationLive cell imaging reveals novel functions of Salmonella enterica SPI2-T3SS effector proteins in remodeling of the host cell endosomal system.The Salmonella effector PipB2 affects late endosome/lysosome distribution to mediate Sif extension.The Salmonella effector SteA contributes to the control of membrane dynamics of Salmonella-containing vacuoles.The Role of Ribonucleases and sRNAs in the Virulence of Foodborne PathogensSlyA regulates function of Salmonella pathogenicity island 2 (SPI-2) and expression of SPI-2-associated genes.The Salmonella enterica PhoP directly activates the horizontally acquired SPI-2 gene sseL and is functionally different from a S. bongori ortholog.Taking possession: biogenesis of the Salmonella-containing vacuole.Salmonella enterica serovar Typhimurium skills to succeed in the host: virulence and regulation.Salmonella enterica highly expressed genes are disease specific.Salmonella phage ST64B encodes a member of the SseK/NleB effector familyCampylobacter jejuni survival within human epithelial cells is enhanced by the secreted protein CiaIFunctions and effectors of the Salmonella pathogenicity island 2 type III secretion system.Host cell type-dependent translocation and PhoP-mediated positive regulation of the effector SseK1 of Salmonella enterica.The ancestral SgrS RNA discriminates horizontally acquired Salmonella mRNAs through a single G-U wobble pair.Salmonella impairs RILP recruitment to Rab7 during maturation of invasion vacuoles.A Highly Effective Component Vaccine against Nontyphoidal Salmonella enterica Infections.Coiled-coil domains enhance the membrane association of Salmonella type III effectors.Crystal Structure of the Salmonella Typhimurium Effector GtgE.Identification of salmonella pathogenicity island-2 type III secretion system effectors involved in intramacrophage replication of S. enterica serovar typhimurium: implications for rational vaccine design.A Bacterial Pathogen Targets a Host Rab-Family GTPase Defense Pathway with a GAP.The Salmonella-containing vacuole: moving with the times.Detection of genomic islands via segmental genome heterogeneity.SseK1 and SseK2 are novel translocated proteins of Salmonella enterica serovar typhimurium.Functional domains and motifs of bacterial type III effector proteins and their roles in infection.GSL-enriched membrane microdomains in innate immune responses.Small RNA functions in carbon metabolism and virulence of enteric pathogens.Salmonella effector SopD2 interferes with Rab34 function.AvrA effector protein of Salmonella enterica serovar Enteritidis is expressed and translocated in mesenteric lymph nodes at late stages of infection in mice.What the SIF Is Happening-The Role of Intracellular Salmonella-Induced Filaments.Secretion and function of Salmonella SPI-2 effector SseF require its chaperone, SscBSalmonella-induced filament formation is a dynamic phenotype induced by rapidly replicating Salmonella enterica serovar typhimurium in epithelial cells.SCAMP3 is a component of the Salmonella-induced tubular network and reveals an interaction between bacterial effectors and post-Golgi trafficking.The Salmonella translocated effector SopA is targeted to the mitochondria of infected cells.Functional analysis of the Salmonella pathogenicity island 2-mediated inhibition of antigen presentation in dendritic cells.General response of Salmonella enterica serovar Typhimurium to desiccation: A new role for the virulence factors sopD and sseD in survival.Probiotics down-regulate genes in Salmonella enterica serovar typhimurium pathogenicity islands 1 and 2.Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole.
P2860
Q21131294-1E5C08B8-6AD8-4388-AC57-C443C82382A1Q22122046-5005F263-DA45-45AE-8601-B29C99C61269Q24678382-84CC292D-2673-4B8E-89B2-41285BF16B6AQ27319876-591BAC13-D50F-48D4-81FC-23F74099F50DQ30476107-273EBD85-416D-447D-BD57-83AD306AA7A2Q30583678-1483DB5F-FAAD-41CD-BD7D-7CAAB9CCE6ABQ33705048-5D821C55-7C69-4790-B8FC-E52D9E4EA0C1Q33883333-D81C9835-8D6A-4D27-883D-426D74C826C5Q33916467-EB3D0D61-921C-4E3C-832F-828A0C12521DQ34221373-70BD40ED-FE8D-48A2-B36C-1B5EE7F5725BQ34336985-3C790C83-0698-4C9E-86C8-DA1384B30533Q34491811-3CC009F4-9E54-4073-A0EB-06566ED31985Q34698809-D65A0C1E-599E-4061-8EA7-4BFAE05FCE58Q35011913-12B031BA-34A6-496B-8DE3-A90DDEC26E95Q35178637-BFA019C5-F31B-45C0-95B7-DB2D21E1029CQ35550681-5CA329A2-3C0F-47C2-AC78-6B0783A2268AQ35882335-E8D21546-BFFB-4DD5-B526-0EC901D5ACC0Q35918621-C02B88DA-265E-4A4E-8146-438B27268962Q36143656-312C43A1-C93D-4493-BFE1-87B35EFDB7A8Q36163397-ADDC9A45-639E-43DB-9F60-DFB273C410F3Q36214183-E701AD79-8C0B-4FA3-8762-71508B9B26BAQ36790792-5B62006B-4978-4BA1-9119-26EEE0CD4019Q36862416-54C3A685-5149-42FD-BB07-F17BF4FD6550Q36961170-6BB96C49-57F3-4E5C-929E-A6B5213AC903Q37384777-F88BBA75-6E4C-420E-B8F9-5EF591918AB1Q37521628-D210781A-46A6-4D52-B9A8-5D9E6BB5045EQ37850977-1CD54ED0-809B-4131-87B4-D8504E180D1BQ38086070-8DBA6A01-1EFB-47EB-8D0F-7702606B52E9Q38235406-3106531D-4A67-4623-BC0F-C2EF3DF4A08CQ38968428-035DB305-C1CE-46A3-A327-5EDA0D3D3438Q39631231-34D7C896-7A64-49FE-82FA-ECCB5D737220Q40101016-7AAAC647-03E3-418F-9460-B3734847C825Q40533728-117A7B57-4794-4B41-9521-29836FD32072Q40994584-DECE90E6-74B0-40C7-B315-60E5B7339228Q42170366-5B3131A2-DB2D-42BF-B073-3326B673B583Q42754908-B783C5AB-A3B9-460C-A847-23396DF79EC1Q43250958-418FB6AB-383D-4CC3-966A-7C504D7C4A8DQ46054906-C7D509C9-1C12-4940-832C-3902C8DA46CBQ46773003-1EBC47B6-314E-4148-B382-FA53C7ACE98FQ50083524-992F8F27-6965-458B-9800-E1944F2D59B8
P2860
SopD2 is a novel type III secreted effector of Salmonella typhimurium that targets late endocytic compartments upon delivery into host cells
description
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Januar 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/01/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/01/01)
@nl
наукова стаття, опублікована в січні 2003
@uk
مقالة علمية (نشرت عام 2003)
@ar
name
SopD2 is a novel type III secr ...... upon delivery into host cells
@ast
SopD2 is a novel type III secr ...... upon delivery into host cells
@en
SopD2 is a novel type III secr ...... upon delivery into host cells
@nl
type
label
SopD2 is a novel type III secr ...... upon delivery into host cells
@ast
SopD2 is a novel type III secr ...... upon delivery into host cells
@en
SopD2 is a novel type III secr ...... upon delivery into host cells
@nl
prefLabel
SopD2 is a novel type III secr ...... upon delivery into host cells
@ast
SopD2 is a novel type III secr ...... upon delivery into host cells
@en
SopD2 is a novel type III secr ...... upon delivery into host cells
@nl
P2093
P2860
P1433
P1476
SopD2 is a novel type III secr ...... upon delivery into host cells
@en
P2093
B Brett Finlay
John H Brumell
Nat F Brown
Sonya Kujat-Choy
P2860
P356
10.1034/J.1600-0854.2003.40106.X
P577
2003-01-01T00:00:00Z